These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8891737)
1. Soluble HLA class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy. Tambutti ML; Ferraris JR; Redal MA; Ramirez JA; Prigoshin N Hum Immunol; 1996 Oct; 50(2):135-9. PubMed ID: 8891737 [TBL] [Abstract][Full Text] [Related]
2. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection. Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168 [TBL] [Abstract][Full Text] [Related]
3. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178 [TBL] [Abstract][Full Text] [Related]
4. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205 [TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-G expression and renal graft acceptance. Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. Bahri R; Naji A; Menier C; Charpentier B; Carosella ED; Rouas-Freiss N; Durrbach A J Immunol; 2009 Dec; 183(11):7054-62. PubMed ID: 19915057 [TBL] [Abstract][Full Text] [Related]
7. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221 [TBL] [Abstract][Full Text] [Related]
8. [Dynamic monitoring of serum soluble HLA class I antigens in renal transplant recipients]. Xu J; Cao Q; Wu D; Ma J; Yu L Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):657-9. PubMed ID: 11829918 [TBL] [Abstract][Full Text] [Related]
9. Detection of soluble HLA-G and its correlation with kidney transplant outcome. Kaneku H Clin Transpl; 2006; ():447-54. PubMed ID: 18365402 [TBL] [Abstract][Full Text] [Related]
10. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
11. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients]. Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537 [TBL] [Abstract][Full Text] [Related]
12. Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection. Ferraris JR; Tambutti ML; Redal MA; Bustos D; Ramirez JA; Prigoshin N Transplantation; 2000 Jul; 70(2):297-301. PubMed ID: 10933152 [TBL] [Abstract][Full Text] [Related]
13. Soluble human leukocyte antigen-G in pediatric renal transplantation. Zarkhin V; Bezchinsky M; Li L; Sarwal MM Transplantation; 2011 Jul; 92(1):e1-2. PubMed ID: 21691191 [No Abstract] [Full Text] [Related]
14. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance. Minguela A; Torío A; Marín L; Muro M; Villar LM; Díaz J; Ramírez P; Parrilla P; García-Alonso AM; Alvarez-López MR Hum Immunol; 1999 Jun; 60(6):500-9. PubMed ID: 10408799 [TBL] [Abstract][Full Text] [Related]
15. Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients. Borelli SD; Ferreira E; Oliveira AM; Krishnaswamy S; Hiraki DD; Grumet FC Hum Immunol; 1999 May; 60(5):430-4. PubMed ID: 10447402 [TBL] [Abstract][Full Text] [Related]
16. Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. DeVito-Haynes LD; Jankowska-Gan E; Meyer KC; Cornwell RD; Zeevi A; Griffith B; Dauber J; Iacono A; Burlingham WJ; Love RB Hum Immunol; 2000 Dec; 61(12):1370-82. PubMed ID: 11163095 [TBL] [Abstract][Full Text] [Related]
17. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of immune status of kidney transplant recipients by combined HLA-G5 and sCD30]. JIN ZK; TIAN PX; XUE WJ; DING XM; PAN XM; DING CG; JIA LN; GE GQ; HAO JJ Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2528-31. PubMed ID: 21092456 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine improves results in HLA-identical sibling renal transplants. Van Buren D; MacDonell R; Johnson HK; Richie R; Ynares C; Helderman JH; Green W; Crowe D Transplant Proc; 1994 Oct; 26(5):2514-5. PubMed ID: 7940772 [No Abstract] [Full Text] [Related] [Next] [New Search]